FDA Arthritis Advisory Committee meeting: methotrexate; guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in scleroderma

Arthritis Rheum. 1986 Oct;29(10):1289-90. doi: 10.1002/art.1780291017.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Dimethyl Sulfoxide / therapeutic use*
  • Humans
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Scleroderma, Systemic / drug therapy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Methotrexate
  • Dimethyl Sulfoxide